DU
ABBV icon

Delphia (USA)’s AbbVie ABBV Stock Holding History

Delphia (USA)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,284
Closed -$364K – 212
2023
Q1 		$364K Buy
2,284
+292
+15% +$44.6K 0.45% 83
2022
Q4 		$322K Buy
+1,992
New +$305K 0.37% 106
2022
Q3 		– Sell
-1,460
Closed -$224K – 282
2022
Q2 		$224K Buy
+1,460
New +$223K 0.15% 255

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Delphia (USA)'s ABBV Position: Q2 2023 in Review

Delphia (USA) sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 2,284 shares — an estimated $364K sold.

Delphia (USA) first reported a position in ABBV in Q2 2022 and held it in 3 quarters. The position peaked at $364K in Q1 2023. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

  • Delphia (USA) reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
  • Delphia (USA) sold 2,284 AbbVie shares in Q2 2023, an estimated $364K.
  • Delphia (USA) first reported a position in AbbVie in Q2 2022 and held it in 3 quarters.
  • Delphia (USA)'s AbbVie position peaked at $364K in Q1 2023.
  • 3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Delphia (USA)'s 13F filing for Q2 2023, filed 14 Aug 2023.